NZ524400A - Process for selectively extracting bioactive components - Google Patents
Process for selectively extracting bioactive componentsInfo
- Publication number
- NZ524400A NZ524400A NZ524400A NZ52440001A NZ524400A NZ 524400 A NZ524400 A NZ 524400A NZ 524400 A NZ524400 A NZ 524400A NZ 52440001 A NZ52440001 A NZ 52440001A NZ 524400 A NZ524400 A NZ 524400A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alcohol
- components
- adsorbent
- raw material
- passageway
- Prior art date
Links
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 35
- 230000008569 process Effects 0.000 title claims abstract description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 144
- 239000000284 extract Substances 0.000 claims abstract description 48
- 239000003463 adsorbent Substances 0.000 claims abstract description 46
- 239000002994 raw material Substances 0.000 claims abstract description 46
- 239000003480 eluent Substances 0.000 claims abstract description 37
- 239000000203 mixture Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 21
- 150000007965 phenolic acids Chemical class 0.000 claims abstract description 17
- 235000009048 phenolic acids Nutrition 0.000 claims abstract description 17
- 229930003949 flavanone Natural products 0.000 claims abstract description 15
- 235000011981 flavanones Nutrition 0.000 claims abstract description 15
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Chemical class O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000013311 vegetables Nutrition 0.000 claims abstract description 11
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 8
- 150000002208 flavanones Chemical class 0.000 claims abstract description 8
- 229930182478 glucoside Natural products 0.000 claims abstract description 8
- 150000001629 stilbenes Chemical class 0.000 claims abstract description 8
- 235000021286 stilbenes Nutrition 0.000 claims abstract description 8
- 244000141359 Malus pumila Species 0.000 claims abstract description 6
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 6
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 6
- 235000021016 apples Nutrition 0.000 claims abstract description 6
- 229920003053 polystyrene-divinylbenzene Polymers 0.000 claims abstract description 6
- 235000012015 potatoes Nutrition 0.000 claims abstract description 6
- 240000000111 Saccharum officinarum Species 0.000 claims abstract description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 claims abstract description 4
- 241000219094 Vitaceae Species 0.000 claims abstract description 4
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 4
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 4
- 239000004410 anthocyanin Substances 0.000 claims abstract description 4
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 4
- 150000008131 glucosides Chemical class 0.000 claims abstract description 4
- 235000021021 grapes Nutrition 0.000 claims abstract description 4
- 229930003944 flavone Natural products 0.000 claims description 11
- 235000011949 flavones Nutrition 0.000 claims description 11
- 150000002213 flavones Chemical class 0.000 claims description 9
- 235000011957 flavonols Nutrition 0.000 claims description 9
- 150000002216 flavonol derivatives Chemical class 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- -1 adroxyflavones Chemical class 0.000 abstract description 10
- 239000002253 acid Substances 0.000 abstract description 3
- 150000007513 acids Chemical class 0.000 abstract description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 22
- 238000004587 chromatography analysis Methods 0.000 description 17
- 241000207199 Citrus Species 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 12
- 229930003935 flavonoid Natural products 0.000 description 9
- 235000017173 flavonoids Nutrition 0.000 description 9
- 150000002215 flavonoids Chemical class 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 6
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 150000002207 flavanone derivatives Chemical class 0.000 description 5
- 150000002630 limonoids Chemical class 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 4
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- 150000001765 catechin Chemical class 0.000 description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 4
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 4
- 229940025878 hesperidin Drugs 0.000 description 4
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- LKMNXYDUQXAUCZ-UHFFFAOYSA-N sinensetin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C=C2O1 LKMNXYDUQXAUCZ-UHFFFAOYSA-N 0.000 description 4
- GIVMXHQLQAIYEX-OJVPXVCRSA-N (1r,2'r,5ar,7ar,9s,11ar,11br)-1-acetyloxy-9-[furan-3-yl-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-5,5,7a,9,11b-pentamethyl-3,7-dioxospiro[2,5a,6,10,11,11a-hexahydro-1h-naphtho[2,1-c]oxepine-8,3'-oxirane]-2'-carboxylic acid Chemical compound C1=COC=C1C([C@@]1(CC[C@H]2[C@@](C11[C@@H](O1)C(O)=O)(C)C(=O)C[C@H]1C(C)(C)OC(=O)C[C@H]([C@]21C)OC(=O)C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GIVMXHQLQAIYEX-OJVPXVCRSA-N 0.000 description 3
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 3
- FYIKIBQJAJRKQM-UHFFFAOYSA-N limonoid glycoside Natural products CC1(C)OC2CC(=O)OCC22C1CC(=O)C(C13C(O3)C(O)=O)(C)C2CCC1(C)C(C1=COC=C1)OC1OC(CO)C(O)C(O)C1O FYIKIBQJAJRKQM-UHFFFAOYSA-N 0.000 description 3
- HXTFHSYLYXVTHC-AJHDJQPGSA-N narirutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O1 HXTFHSYLYXVTHC-AJHDJQPGSA-N 0.000 description 3
- HXTFHSYLYXVTHC-ZPHOTFPESA-N narirutin Natural products C[C@@H]1O[C@H](OC[C@H]2O[C@@H](Oc3cc(O)c4C(=O)C[C@H](Oc4c3)c5ccc(O)cc5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O HXTFHSYLYXVTHC-ZPHOTFPESA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- QEWSAPKRFOFQIU-UHFFFAOYSA-N 5-Hydroxy-6,7,3',4'-tetramethoxyflavone Natural products C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C=C2O1 QEWSAPKRFOFQIU-UHFFFAOYSA-N 0.000 description 2
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 2
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 2
- 235000010209 hesperetin Nutrition 0.000 description 2
- 229960001587 hesperetin Drugs 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- FYIKIBQJAJRKQM-WNCNYDOCSA-N limonin 17-beta-D-glucoside Chemical compound O([C@H]([C@@]1(CC[C@H]2[C@@]([C@@]11[C@H](O1)C(O)=O)(C)C(=O)C[C@@H]1[C@]32COC(=O)C[C@@H]3OC1(C)C)C)C1=COC=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FYIKIBQJAJRKQM-WNCNYDOCSA-N 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 150000008163 sugars Chemical group 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZIKZPLSIAVHITA-UHFFFAOYSA-N Nomilinic acid Natural products CC(=O)OC(CC(O)=O)C1(C)C(C(C)(C)O)CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 ZIKZPLSIAVHITA-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000009704 beneficial physiological effect Effects 0.000 description 1
- 150000001562 benzopyrans Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- ZIKZPLSIAVHITA-GBCWXVSRSA-N chembl2269933 Chemical compound C=1([C@@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@H]([C@]4(C)[C@@H](CC(O)=O)OC(=O)C)C(C)(C)O)C=COC=1 ZIKZPLSIAVHITA-GBCWXVSRSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/733—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
A process for selectively extracting bioactive components from a raw material extract derived from vegetable matter comprises: (a) passing the raw material extract through a passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed on to the adsorbent; (b) subsequently passing through the passageway an eluent mixture substantially containing water and alcohol whereby the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 vol percent to 95 vol percent during at least those periods when the components are being eluted and (c) sequentially collecting an eluate in fractions corresponding to the presence of the extracted components. A process for selectively extracting bioactive components from a raw material extract derived from vegetable matter comprises: (a) combining the raw material extract with sufficient alcohol to ensure at least one bioactive component will not be adsorbed when the combined raw material and alcohol are passed through a first passageway containing adsorbent; (b) passing the combined raw material extract and alcohol through a first passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed on to the adsorbent; (c) reducing the alcohol component of the combined raw material extract and alcohol to less than 15 vol percent; (d) passing the combined raw material extract and remaining alcohol through a second passageway containing an adsorbent whereby remaining components to be extracted are adsorbed on to the adsorbent; (e) subsequently passing through the first passageway an eluent mixture substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 50 vol percent to 95 vol percent during at least those periods when the components are being eluted. (f) subsequently passing through the second passageway an eluent mixture substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 vol percent to 35 vol percent during at least those periods when the components are being eluted and (g) sequentially collecting from each passageway an eluent in fractions corresponding to the presence of the bioactive components. The adsorbent can be polystyrene-divinyl benzene and the alcohol can be ethanol. The vegetable matter can be citrus fruit, sugar cane, apples, potatoes, or a mixture of apples and potatoes or grapes and the bioactive components can be limomoid glucosides, flavanones, polymethoxylatedflavones, arephenolic acids, hydroxyflavones, phenolic acids, proanthocyanidins, adroxyflavones, stilbenes, proanthocyanidins, phenolic acids and/or anthocyanins.
Description
WO 02/20112 PCT/AU01/01113 1 PROCESS FOR SELECTIVELY EXTRACTING BIOACTIVE COMPONENTS Field of the Invention The invention relates to a process for extracting components from fruits and/or plants. The invention particularly but not exclusively relates to a process for selectively extracting components containing limonoid glucosides, flavanones and polymethoxylated flavones from a raw material composed of citrus juice, citrus molasses and/or peel water. The invention also particularly but not 10 exclusively relates to phenolic acids and hydroxy flavones from a raw material composed of sugar cane. The invention also particularly but not exclusively relates to a process for selectively extracting components respectively containing phenolic acids, proanthocyanidins, hydroxy flavones and flavonols from from a raw material composed of apples and/or potatoes. The invention 15 also particularly but not exclusively relates to a process for selectively extracting components respectively containing flavonols, stilbenes, proanthocyanidins, phenolic acids and anthocyanins from a raw material composed of grapes.
Background of the Invention Citrus fruits contain a range of compounds which are biologically active in humans. Many of these compounds have a beneficial antioxidant activity with the ability to produce advantageous physiological effects in the treatment of conditions such as cancer, heart disease, high blood pressure and arthritis. For 25 example citrus limonoid compounds derived from citrus may be used as anti-tumour agents. Further studies have also identified beneficial physiological effects produced by Flavonoids such as Flavanones and Polymethoxylated Flavones.
The bioactive compounds present in citrus fruits include groups consisting of Limonoids and Flavonoids.
Limonoids are a group of triterpenoid derivatives found in naturally occurring substances such as citrus fruits. The compounds which typically occur in citrus WO 02/20112 PCT/AU01/01113 2 fruits are linked to a glucose molecule (the glucoside) and are commonly referred to as limonoid glucosides.
Flavonoids belong to the group of benzopyrane derivatives which occur widely 5 in nature. They have a typical chemical structure consisting of one benzene ring with a fused heterocyclic six membered ring containing an oxygen atom. These compounds also contain phenolic hydroxyl groups, which may be free, methylated or bound to sugars. Typically, flavonoids are distinguished by means of differences between the heterocyclic rings and between additional 10 functional groups. Three types of flavonoids occur in citrus fruits - flavanones, flavones and flavonols. Many of these exist as glycosides.
Flavanones are the most predominant type of citrus flavonoid. In fruits such as sweet orange, mandarin and lemon the dominant flavanone is the nearly 15 tasteless hesperidin, while in more bitter fruits such as grapefruit, pummelo and sour orange, the more bitter flavanone naringin dominates.
The term polymethoxylated flavones represents the chemical family of flavones with a number of methoxyl groups equal to or greater than 4. These 20 compounds are almost exclusively found in citrus fruits with a specific characteristic distribution for each variety. They are found in all parts of the fruit including the peel, flavedo, albedo and endocarp.
In the citrus processing industry, a commercial practice has arisen of producing 25 juice or juice additives from citrus peel. In this process water soluble components are extracted from the peel using a range of devices. The resultant extract is typically bitter and astringent due to the large amounts of limonoid and flavonoid compounds which are particularly concentrated in the peel. To ensure the juice is not overly bitter the extract is typically clarified and 30 de-bittered. The de-bittering process involves contacting the extract with a polymer adsorbent. This results in the adsorption on the polymer of some of the bitter principles; the remaining natural sugars, acids and some flavour compounds remain in the treated "juice". This treatment results in the WO 02/20112 PCT/AU01/01113 3 adsorption of a large portion of the flavonoid compounds in addition to the limonoids.
Commercial de-bittering operations typically regenerate the polymer by 5 desorbing the removed compounds with a caustic soda solution. This process destroys the bioactive and flavour components resulting in their discharge as waste with the spent caustic solution, without harnessing these valuable bioactive by-products.
The object of the present invention is to address some or all of these problems, and to effect a separation of individual bioactive components.
Summary of the Invention According to the present invention, there is provided a process for selectively 15 extracting bioactive components from a raw material extract derived from vegetable matter, including the steps of: (a) passing said raw material extract through a passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed on to the said adsorbent; (b) subsequently passing through said passageway an eluent mixture substantially containing water and alcohol whereby the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 vol percent to 95 vol percent during at least those periods when the components are being eluted; (c) sequentially collecting an eluate in fractions corresponding to the presence of the extracted components.
One embodiment of the present invention in particular provides a process for selectively extracting components respectively containing limonoid glucosides, 30 flavanones and polymethoxylated flavones from a raw material composed of citrus juice, citrus molasses and/or peel water including the steps of: (a) passing said raw material through a passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed onto the said adsorbent; WO 02/20112 PCT/AU01/01113 4 (b) subsequently passing through said passageway an eluent mixture substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 voI% to 95vol% during at least those periods when the components are being eluted; (c) sequentially collecting an eluate in fractions corresponding to the presence of the extracted components.
Usually, the flavanones extracted are flavanone glycosides.
The present invention also provides processes for selectively extracting components respectively containing phenolic acids and hydroxy flavones from raw material composed of sugar cane; or phenolic acids, proanthocyanidins, hydroxy flavones and flavonoles from raw material composed of apples and/or 15 potatoes; or flavonols, stilbenes, proanthocyanidins, phenolic acids and anthocyanins from raw materials composed from grapes; said process including steps (a) to (c) above.
A further embodiment of the invention provides a process for selectively 20 extracting bioactive components from a raw material extract derived from vegetable matter, including the steps of: (a) combining said raw material extract with sufficient alcohol to ensure at least one bioactive component will not be adsorbed when the combined raw material extract and alcohol are passed through a first passageway containing adsorbent; (b) passing said combined raw material extract and alcohol through a first passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed on to the said adsorbent; (c) reducing the alcohol component of the combined raw material extract 30 and alcohol to less than 15 vol percent; (d) passing the combined raw material extract and remaining alcohol through a second passageway containing an adsorbent whereby remaining components to be extracted are adsorbed on to the said adsorbent; WO 02/20112 PCT/AU01/01113 (e) subsequently passing through said first passageway an eluent mixture substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 50 vol percent to 95 vol percent during at least those periods when the components are being eluted. (f) subsequently passing through said second passageway an eluent mixture substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 vol percent to 35 vol percent during at least those periods when the components are being eluted; (g) sequentially collecting from each passageway an eluent in fractions corresponding to the presence of the bioactive components.
The raw material provided can be in any suitable form. Where components are 15 extracted from citrus fruit this raw material may include extracts from all parts of the fruit. Furthermore, where components are extracted from citrus fruit, a particularly suitable raw material consists of extract from the peel. A high concentration extract from citrus peel may be obtained using counter current extraction of sliced citrus peel with water.
The raw material may also be treated in any suitable manner before being processed by the invention. Processing by centrifuge and/or filtration to minimise the amount of suspended solids in the solution is particularly desirable.
The passageway(s) of the present invention may be provided in any suitable form. This may be provided by packing a column, container, vessel or pipe with adsorbent. A gravity fed packed column is a particularly suitable form of passageway. The column may be packed in any suitable manner with any 30 suitable arrangement of adsorbent beads. Preferably the ratio of the length of the column to its diameter is 4:1 or greater.
WO 02/20112 PCT/AU01/01113 6 The adsorbent may be provided in any suitable form. A particular suitable form for the adsorbent is in the form of beads which can be in any suitable shape and size. Preferably, the adsorbent used is polystyrene-divinyl benzene.
Furthermore, any suitable alcohol may be used to elute the components from the raw material. In a particularly preferred form of the invention, the alcohol is ethanol.
Where alcohol has been combined with the raw material extract so as to ensure 10 at least one bioactive component is not adsorbed during passage through the first passageway, the volume percentage of alcohol in the combined alcohol/raw material extract is reduced to less than 15 voI% prior to passing through the second passageway. This is preferably carried out by removing alcohol from the combined alcohol/raw material extract in an evaporator.
The fractions may be collected in any suitable manner. Any suitable number of fractions may be collected. The collection of fractions may be arranged to maximise the concentration of a desired component in a particular fraction. Preferably, an in-line spectrophotometer is used to detect the presence of 20 specific components in the eluate and indicate suitable fractions.
The concentration of alcohol in the eluent mixture can be increased at any suitable, substantially constant rate whilst the eluate contains the components of interest. The alcohol concentration may be increased from 15 vol% to 45 25 vol% over a period of approximately 7.5 hours. The alcohol concentration may be increased from 75 vol% to 95 vol% over a period of approximately 5 hours. In a preferred form of the invention, the rate at which the alcohol concentration of the solution is increased is greater between 45 vol% to 75 vol% alcohol, as the components of interest are not eluted over this range.
Where the raw material extract contains more than three bioactive components with a wide range of hydrophobicity, problems may be encountered in separating the components. Recovery of strongly hydrophobic components may result in excessive losses of relatively hydrophilic components.
WO 02/20112 PCT/AU01/01113 7 Accordingly, in a preferred form of the invention, the adsorption step is carried out using two passageways containing adsorbent. Alcohol is added to the raw material extract to a level calculated to ensure that the more hydrophilic components will not be adsorbed by the adsorbent, and the alcohol/raw material 5 extract mixture is passed through a first passageway to adsorb the more hydrophobic components. The more hydrophobic components are then eluted from the first passageway using a water/alcohol eluent as previously described.
. The alcohol/raw material extract mixture containing the more hydrophilic 10 components, which are not adsorbed is de-alcoholised to a level where the more hydrophilic components will be adsorbed when in contact with the adsorbent, and is passed through a second passageway for adsorption. The more hydrophilic components are then eluted from the second passageway using a water/alcohol eluent as previously described.
By using this technique it has been found that there is a marginal improvement in the efficiency of separation of biocactive components, and a significant improvement in the capacity of a given volume of polymer adsorbent to load bioactive components without loss of yield.
The process may include the additional step of processing the eluted fractions further by evaporating the alcohol to yield a further concentrated form of the extracted component. The concentrated form of the extracted component may then be freeze dried or incorporated into an oil base for storage, transport or 25 use.
In a particularly preferred form of the invention the presence of a particular extracted component in the eluate is detected by an in-line spectrophotometer.
Brief Description of the Drawings The invention will now be described in further detail by reference to the enclosed drawings which relate to an example form of the invention. It is to be WO 02/20112 PCT/AU01/01113 8 understood that the particularity of the example and the drawings do not supersede the generality of the preceding description of the invention.
Figure.1 illustrates a graph of ethanol concentration in eluent mixture overtime.
Figure 2 illustrates a graph of alcohol concentration varying with fraction number.
Figure 3 is a chromatographic analysis illustrating the presence of Limonin 10 Glucoside in fractions collected.
Figure 4 is a chromatographic analysis illustrating the presence of Nomilin Glucoside in fractions collected.
Figure 5 is a chromatographic analysis illustrating the presence of the Flavanone Glycoside Narirutin in fractions collected.
Figure 6 is a chromatographic analysis illustrating the presence of the Flavanone Glycoside Hesperidin in fractions collected.
Figure 7 is a chromatographic analysis illustrating the presence of the Flavanone Aglycone Hesperetin in fractions collected.
Figure 8 is a chromatographic analysis illustrating the presence of Limonin in 25 fractions collected.
Figure 9 is. a chromatographic analysis illustrating the presence of the Polymethoxylated Flavone Sinensetin in fractions collected.
Figure 10 is a chromatographic analysis illustrating the presence of the Polymethoxylated Flavone Nobiletin in fractions collected.
Figure 11 is a schematic diagram of a plant for carrying out one embodiment of the process of the invention. Note that the number of evaporators in the WO 02/20112 PCT/AU01/01113 9 process is directly related to the number of bioactive component fractions to be recovered.
Detailed Description In one preferred embodiment of the invention, a multiple stage counter current diffusion extractor is used to separate water soluble juice compounds from water insolubles. The resulting juice is at least partially depectinised, pasteurised and clarified. This may be done with either a self desludging high 10 speed centrifuge or by filtration.
The clarified juice is then contacted with an adsorbent which preferentially adsorbs the limonoid glucosides, flavanones and polymethoxylated flavones. A suitable device for the purposes of effecting contact between the juice is an 15 automated twin column polymer adsorption device.
After a sufficient build up of adsorbed components on the adsorbent, the flow of juice to the adsorbent column is stopped. The column is then fed with a mixture of water and alcohol. This eluent mixture is delivered to the column at a 20 predetermined rate varying between 1 and 5 bed volumes per hour.
The concentration of alcohol in the eluent is increased until it reaches approximately 15% vol alcohol. The concentration of alcohol in the eluent is increased at a substantially constant rate until the alcohol concentration in the 25 entering solution reaches approximately 45% vol. In one particular embodiment of the invention the alcohol content is increased more rapidly from 45% vol to 75%vol. The concentration of alcohol in the eluent is then increased at a substantially constant rate from 75%vol, until it reaches 95%voI. The liquid leaving the column is collected in fractions. This liquid may be analysed after 30 leaving the column by the use of an in-line spectrophotometer.
In another preferred embodiment of the invention, an extract containing bioactive components is obtained from grape skins. The extract contains the following bioactive components in order of hydrophobicity: stilbenes (including WO 02/20112 PCT/AU01/01113 resveratrol), flavonols (including quercetin and myricetin), catechins and phenolic acids. The stilbenes are very strongly hydrophobic, whilst the phenolic acids are relatively hydrophilic.
To ensure maximum recovery of stilbenes, whilst avoiding excessive losses of phenolic acids, alcohol is added to the extract until the resultant extract/alcohol mixture is approximately 58% alcohol. This ensures that the phenolic acids and the catechins will not be adsorbed when in contact with an adsorbent. The extract/alcohol mixture is then passed through a first adsorbent column, 10 preferably packed with polystyrene-divinyl benzene beads as adsorbent. The stilbenes and flavonols are selectively adsorbed on the first column whilst the remaining extract/alcohol mixture, containing catechins and phenolic acids passes through the first column. Alcohol is then removed from the remaining extract/alcohol mixture to reduce the alcohol content to approximately 7% to 15 10%, and the de-alcoholised mixture is passed through a second adsorption column, preferably containing polystyrene-divinyl benzene adsorbent, where the catechins and phenolic acids are adsorbed.
Each of the adsorbent columns is then fed with an eluent mixture of water and 20 alcohol. The concentration of alcohol in the eluent is gradually increased, and fractions containing different bioactive components are collected. The concentration of alcohol in the eluent for the first column is increased at a substantially constant rate, preferably from about 50% to about 96% alcohol. The eluent for the second column is also increased at a substantially constant 25 rate, preferably from about 15% to 35% alcohol.
Figure 11 is a schematic diagram of a plant suitable for carrying out a preferred embodiment of the process according to the invention. As shown in the diagram, a raw plant material extract is fed from an extractor (1) to a stirred tank 30 (2). The extract is then loaded to a first column (3), along with ethanol from the ethanol tank (4) and water from water tank (7). Relatively hydrophobic compounds are adsorbed on an adsorbent in column (3), whilst relatively hydrophilic compounds pass through column (3) to ethanol recovery evaporators (5), which remove most of the ethanol. The removed ethanol is WO 02/20112 PCT/AU01/01113 11 returned to the ethanol tank (4) via distillation unit (10). The de-alcoholised extract is loaded to a second column (6) where the hydrophilic components are adsorbed on an adsorbent. Further ethanol is removed from the treated extract discharged from the second column (6) in ethano! recovery evaporators (5), and 5 the treated extract is then discharged for disposal, or if desired, further treatment or use (13).
A mixture of ethanol from ethanol tank (4) and water from water tank (7) is then added to each of the columns (3, 6). The proportion of alcohol to water is 10 increased over time so as to elute the bioactive components as separate fractions. The separate factions are each sent to a product evaporator (8, 9) for removal of alcohol and water to concentrate the bioactive component. The number of product evaporators (8, 9) will depend upon the number of fractions containing bioactive components; ideally each fraction will go to a separate 15 product evaporator. The alcohol and water removed from the bioactive component is sent to a distillation unit (10) where alcohol is recovered and returned to the ethanol tank (4). The remaining components from the distillation unit are sent to distillation waste (12). The concentrated bioactive components obtained from the product evaporators (8, 9) are then freeze dried in freeze 20 drier (11) for storage and transportation. In an alternative embodiment, (not shown), the concentrated bioactive components may be combined with an oil base, rather than freeze dried.
It should be noted that there might be some losses of ethanol during the 25 process; for this reason make-up ethanol (14) may need to be added to the ethanol tank (4) from time to time. Preferably there are four columns (3, 6, 15, 16) being loaded and/or eluted at any one time.
Example The following example illustrates the present invention in further detail, it being understood, however, that this example should by no means be construed as defining the scope of the invention WO 02/20112 PCT/AU01/01113 12 Orange peel was obtained and shaved using suitable shaving equipment. The shavings were then stored in 200 litre drums and stored at -18°C for two days. The drums were then stored at 5°C for a further two days in preparation for the extraction.
The shavings were sliced in a slicer with a 4mm gap. Sliced pieces were then fed into a counter current diffusion extractor at a rate of 1.2kg per 5 minutes, and extracted with hot water. The juice generated was pumped via a heat exchanger to 60 litre tanks. The resulting juice was at an approximate 10 temperature of 25°C. Sixty grams of citric acid were then added to the base of each empty juice tank to provide approximately 1 gram of citric acid per litre of juice. The addition of citric acid ensured a low pH level ensuring that the pH in each tank did not exceed 3.8. Ascorbic acid was also added to the base of each tank, to result in the overall addition of 100ppm of ascorbic acid to all juice 15 in this batch.
The juice was partially depectinised by adding 10 mis of Vinozym 3XL per 50 litre juice. Each tank was then pasteurised at 93°C for 90 seconds. The depectinised juice was then fed to a self desludging centrifuge at the rate of 220 20 litres per hour to further clarify the juice.
The centrifuged juice (total 152.4 kg) was then fed into gravity feed column containing a 20 litre bed of polystyrene-divinyl benzene copolymer XAD 16. The bed was prepared by washing respectively with the following solutions (i) 2 25 bed volume of water (ii) 1 bed volume of 2% Sodium Hydroxide (ii) 2 bed volume of water (iv) 1 bed volume of citric acid and (v) 2 bed volume of water.
The clarified juice was then passed through the column at a rate of 1 bed volume (20 litres) per hour. The column was flushed with 2 bed volumes of 30 deionised water and a further 2 bed volumes of 10% vol ethanol in water mixture. This treatment with deionised water and alcohol solution was to remove sugar and acid from the column as well as a proportion of the weakly hydrophobic phenolic compounds adsorbed onto the adsorbent, without removing a substantial portion of the Limonoid and Flavonoid components. 13 A mixture of ethanol and demineralised water was then was passed through the column at a continuous rate of one bed volume per hour resulting in a feed rate of 20 litres per hour. The initial concentration of ethanol in the mixture was 10 5 vol% this was increased to 15 vol% ethanol. The concentration was then increased at a constant rate of 10 vol% for each 2.5 bed volumes of eluent. This meant that the alcohol concentration increased from 15 vol% to 45 vol% over 7.5 hours. The concentration was then kept at 45 vol% for an hour. After this period the concentration of ethanol in the mixture was rapidly increased to 10 75 vol% ethanol. Over the next 5 hours the concentration was increased constantly from 75 vol% to 95 vol% ethanol. An example of the change in ethanol concentration in the mixture entering the column over time during the adsorption is illustrated in Figure 1. The mixture leaving the column was then passed through an in-line spectrophotometer to determine the amount of 15 recoverable components in each of the fractions. The liquid leaving the column was then collected in equal fractions which were sequentially numbered 1 to 111, and represented the total eluate over the course of the experiment.
The alcohol concentration leaving the column was then analysed. Alcohol 20 volume (as a percentage of liquid leaving the column) plotted against the fraction number is illustrated in Figure 2.
The fractions were analysed using high-pressure liquid chromatography (HPLC) and results are set out in Figures 3 to 10. The components were identified by 25 comparing the relative peak heights with standards from those compounds having the same retention time and ultra violet spectra. These figures illustrate the chromatographic analysis of a variety of components present in fractions leaving the column. Figure 3 illustrates a chromatographic analysis of Limonin Glucoside in fractions leaving the column. Figure 4 illustrates a 30 chromatographic analysis of Nomilin Glucoside in fractions leaving the column. Figure 5 illustrates a chromatographic analysis of Narirutin in fractions leaving the column. Figure 6 illustrates a chromatographic analysis of Hesperidin in fractions leaving the column. Figure 7 illustrates a chromatographic analysis of Hesperetin leaving in fractions leaving the column. Figure 8 illustrates a WO 02/20112 PCT/AU01/01113 14 chromatographic analysis of Limonin in fractions leaving the column. Figure 9 illustrates a chromatographic analysis of Senensetin in fractions leaving the column. Figure 10 illustrates a chromatographic analysis of Nobiletin in fractions leaving the column.
Each of the fractions leaving the column was then treated by evaporating the alcohol to leave a concentrated solution including the desired components. After the evaporation step, the remaining components were freeze dried for storage.
The total amount of target components recovered from 1 kg of Orange albedo was determined by adding together the amounts from all fractions to determine the following compositions - Limonin glucoside : 282 mg Nomilin glucoside (including Nomilinic acid): 177 mg Narirutin : > 80 mg Hesperidin : > 80 mg Sinensetin : 11 mg Other compounds considered to be polymethoxylated flavones : >11 mg These compositions are for all fractions together. The components are concentrated in different fractions, for example Limonin glucoside was eluted in the first four fractions.
These numbers are indicative only and were produced after a single trial.
It is to be understood that various additions, alterations and/or modifications may be made to the parts previously described without departing from the ambit of the invention.
WO 02/20112 PCT/AU01/01113
Claims (13)
1. A process for selectively extracting bioactive components from a raw material extract derived from vegetable matter, including the steps of: 5 (a) passing said raw material extract through a passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed on to the said adsorbent; (b) subsequently passing through said passageway an eluent mixture 10 substantially containing water and alcohol whereby the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 vol percent to 95 vol percent during at least those periods when the components are being eluted; 15 (c) sequentially collecting an eluate in fractions corresponding to the presence of the extracted components.
2. A process for selectively extracting bioactive components from a raw material extract derived from vegetable matter, including the steps of: 20 (a) combining said raw material extract with sufficient alcohol to ensure at least one bioactive component will not be adsorbed when the combined raw material and alcohol are passed through a first passageway containing adsorbent; 25 (b) passing said combined raw material extract and alcohol through a first passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed on to the said adsorbent; 30 (c) reducing the alcohol component of the combined raw material extract and alcohol to less than 15 vol percent; (d) passing the combined raw material extract and remaining alcohol through a second passageway containing an adsorbent whereby WO 02/20112 PCT/AU01/01113 16 remaining components to be extracted are adsorbed on to the said adsorbent; (e) subsequently passing through said first passageway an eluent mixture 5 substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 50 vol percent to 95 vol percent during at least those periods when the components are being eluted. 10 (f) subsequently passing through said second passageway an eluent mixture substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 vol percent to 35 vol percent during at least those periods when the components are being eluted; 15 (g) sequentially collecting from each passageway an eluent in fractions corresponding to the presence of the bioactive components.
3. A process according to claim 1 wherein the rate of increased of alcohol 20 concentration of the eluent is greater between 45 vol percent to 75 vol percent alcohol.
4. A process according to claim 2 in which reduction of the alcohol component of the combined raw material extract and alcohol to less than 25 15 vol percent is achieved by removing alcohol in an evaporator.
5. A process according to claim 1 or claim 2 wherein the said adsorbent is polystyrene-divinyl benzene. 30
6. A process according to claim 1 or claim 2 wherein said alcohol is ethanol.
7. A process according to claim 1 or claim 2, including the additional step of processing said fractions further by evaporating the alcohol to yield a further concentrated form of the extracted component. WO 02/20112 17 PCT/AU01/01113
8. A process according to claim 1 or claim 2 in which the vegetable matter is selected from citrus fruit and the bioactive components are limomoid glucosides, flavanones and polymethoxylated flavones. 5
9. A process according to claim 1 or claim 2 in which the vegetable matter is sugar cane and the bioactive components are phenolic acids and hydroxy flavones.
10. 10 10. A process according to claim 1 or claim 2 in which the vegetable matter is selected from apples, potatoes, or a mixture of apples and potatoes, and the bioactive components are phenolic acids, proanthocyanidins, adroxyflavones and flavonols. 15
11. A process according to claim 1 or claim 2 in which the vegetable matter is grapes and the bioactive components are flavonols, stilbenes, proanthocyanidins, phenolic acids and anthocyanins.
12. A process, substantially as herein described, with reference to the 20 example.
13. A process, substantially as herein described, with reference to anyone of the drawings.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ9874A AUPQ987400A0 (en) | 2000-09-04 | 2000-09-04 | Process for selectively extracting bioactive components |
| PCT/AU2001/001113 WO2002020112A1 (en) | 2000-09-04 | 2001-09-04 | Process for selectively extracting bioactive components |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ524400A true NZ524400A (en) | 2004-08-27 |
Family
ID=3823928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ524400A NZ524400A (en) | 2000-09-04 | 2001-09-04 | Process for selectively extracting bioactive components |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7238379B2 (en) |
| EP (1) | EP1324809B1 (en) |
| JP (1) | JP2004507563A (en) |
| AT (1) | ATE309850T1 (en) |
| AU (1) | AUPQ987400A0 (en) |
| CA (1) | CA2420881C (en) |
| DE (1) | DE60115076D1 (en) |
| ES (1) | ES2250469T3 (en) |
| NZ (1) | NZ524400A (en) |
| WO (1) | WO2002020112A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4498684B2 (en) * | 2003-03-17 | 2010-07-07 | 株式会社 エフェクト | Eye strain improvement / prevention agent |
| JP2005145824A (en) * | 2003-11-11 | 2005-06-09 | Maruzen Pharmaceut Co Ltd | Method for producing nobiletin |
| BRPI0511227A (en) | 2004-06-04 | 2007-11-27 | Horizon Science Pty Ltd | molasses extract, sugar sludge extract, broth and / or foam extract collected from the clarification tank, extract of fibrous / residual sugarcane stalks from the sugar beet or sugarcane field, bagasse extract and extract of sugar beet pulp having characteristics reducing ig or burning rate; method for the extraction of non-nutrient phytochemicals which have reducing properties of ig or the rate of burning of sugar processing waste stream and other products in process and sugarcane milling sludge; method for decreasing the ig of a food product; sucrose product containing low ig; method for obtaining food products having a lower ig or lower burn rate; method to improve health; method for decreasing the ig of a sucrose-containing product; low ig product; purified phytochemical extracted from sugar cane or sugar beet; low ig sweetener and sweetener |
| US7550167B1 (en) | 2004-09-02 | 2009-06-23 | Florida Department Of Citrus | Grapefruit-juice-based beverage preparation method for the elimination of drug absorption interaction |
| AU2005320635B2 (en) * | 2004-12-27 | 2008-06-19 | Amano Enzyme Inc. | Antioxidant material, anti-deterioration agent and food or beverage |
| EP2450084B1 (en) | 2005-06-03 | 2014-02-19 | Horizon Science Pty Ltd | Substances having body mass redistribution properties |
| WO2008034180A1 (en) | 2006-09-19 | 2008-03-27 | Horizon Science Pty Ltd | Extracts derived from sugar cane and a process for their manufacture |
| MX2010003775A (en) * | 2007-10-09 | 2010-04-21 | Tropicana Prod Inc | Control of flavor characteristics of and indicator of freshness in fruit juice. |
| NZ585206A (en) * | 2007-10-10 | 2012-06-29 | Langtech Internat Pty Ltd | Method to recover bioactive compounds |
| WO2009140394A1 (en) * | 2008-05-13 | 2009-11-19 | Cargill, Incorporated | Separation of rebaudioside a from stevia glycosides using chromatography |
| US20100159115A1 (en) * | 2008-12-19 | 2010-06-24 | Niv Ben Yehuda | Flavonoid-rich citrus extract process |
| US20100159100A1 (en) * | 2008-12-19 | 2010-06-24 | Olivier Buysschaert | Flavonoid-rich citrus extract and compositions thereof |
| ES2523997T3 (en) * | 2009-06-16 | 2014-12-03 | Epc (Beijing) Natural Products Co., Ltd. | Reduction or elimination of residual flavor in a sweetener using rebaudioside D |
| KR20110138001A (en) * | 2010-06-18 | 2011-12-26 | (주)아모레퍼시픽 | Composition comprising colored-bean extracts |
| KR20110138000A (en) * | 2010-06-18 | 2011-12-26 | (주)아모레퍼시픽 | Composition containing colored soybean extract |
| US9578895B2 (en) | 2010-08-23 | 2017-02-28 | Epc (Beijing) Natural Products Co., Ltd. | Rebaudioside A and stevioside compositions |
| US10334870B2 (en) | 2010-10-07 | 2019-07-02 | Tropicana Products, Inc. | Processing of whole fruits and vegetables, processing of side-stream ingredients of fruits and vegetables, and use of the processed fruits and vegetables in beverage and food products |
| AU2012214104C1 (en) | 2011-02-08 | 2017-08-03 | Poly Gain Pte Ltd | Sugar extracts |
| US9795156B2 (en) | 2011-03-17 | 2017-10-24 | E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd | Rebaudioside B and derivatives |
| CN102603697B (en) * | 2012-02-06 | 2014-07-23 | 安岳华亿柠檬开发有限公司 | Process for extracting polymethoxylated flavones from lemon |
| BR112015004520B1 (en) | 2012-08-28 | 2021-10-05 | The Product Makers (Australia) Pty Ltd | PROCESS FOR THE PRODUCTION OF AN EXTRACT, EXTRACT, COMPOSITION, FOOD, DRINKS AND USE OF SUCH EXTRACT, METHOD TO REDUCE THE CALORIC VALUE AND/OR REDUCE THE GI OF A FOOD OR BEVERAGE |
| CN103091437B (en) * | 2012-11-13 | 2014-12-24 | 江苏艾兰得营养品有限公司 | Determination method of hesperidin content |
| CN102944623A (en) * | 2012-11-21 | 2013-02-27 | 福建农林大学 | Determination method of limonin and nomilin in kumquat |
| MX2015009165A (en) | 2013-02-15 | 2015-11-09 | Pepsico Inc | Preparation and incorporation of co-products into beverages to enhance nutrition and sensory attributes. |
| CN105722520A (en) | 2013-08-16 | 2016-06-29 | 产品制造商(澳大利亚)有限公司 | Sugarcane-derived extracts and methods of treatment |
| US10264811B2 (en) | 2014-05-19 | 2019-04-23 | Epc Natural Products Co., Ltd. | Stevia sweetener with improved solubility |
| US10357052B2 (en) | 2014-06-16 | 2019-07-23 | Sweet Green Fields USA LLC | Rebaudioside A and stevioside with improved solubilities |
| US10485256B2 (en) | 2014-06-20 | 2019-11-26 | Sweet Green Fields International Co., Limited | Stevia sweetener with improved solubility with a cyclodextrin |
| GB201420902D0 (en) * | 2014-11-25 | 2015-01-07 | Neem Biotech Ltd | A process for producing Ajoene |
| IT201700057761A1 (en) * | 2017-05-26 | 2018-11-26 | Consiglio Per La Ricerca In Agricoltura E Lanalisi Delleconomia Agraria | Method for the production of an extract from by-products of citrus processing and extract thus obtained |
| CN108642117B (en) * | 2018-03-06 | 2020-12-15 | 北京颐方生物科技有限公司 | Method for extracting limonin and nomilin |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2661907A (en) * | 1951-03-30 | 1953-12-08 | Honeywell Regulator Co | Control apparatus for steam heating systems |
| CH634726A5 (en) * | 1978-09-29 | 1983-02-28 | Nestle Sa | PROCESS FOR THE PREPARATION OF ANTIOXYGEN SUBSTANCES. |
| CA2128293C (en) * | 1993-12-06 | 2002-09-03 | Masayuki Tanabe | Fruit polyphenols and medicinal compositions containing them |
| IT1269862B (en) * | 1994-05-30 | 1997-04-15 | Indena Spa | FOETIDA MAP ALKALOIDS, THEIR USE AND FORMULATIONS CONTAINING THEM |
| US5679806A (en) * | 1995-02-24 | 1997-10-21 | Hauser, Inc. | Process for the isolation and purification of isoflavones |
| JPH09110714A (en) * | 1995-10-17 | 1997-04-28 | Wakayama Aguri Bio Kenkyu Center:Kk | Production of limonoid glycoside |
| FR2744365B1 (en) * | 1996-02-06 | 1998-02-27 | Inst Malgache Rech Appl | INSULABLE MIXTURES FROM EUGENIA JAMBOLANA LAMARCK SEEDS, THEIR PREPARATION AND THE USE OF SUCH MIXTURES AND SOME OF THEIR CONSTITUENTS AS MEDICAMENTS |
| US5817354A (en) * | 1996-08-22 | 1998-10-06 | Sepragen Corporation | High throughput debittering |
| IL127371A (en) * | 1998-12-02 | 2004-08-31 | Adumin Chemicals Ltd | Method for selectively obtaining antioxidant rich extracts from citrus fruits |
-
2000
- 2000-09-04 AU AUPQ9874A patent/AUPQ987400A0/en not_active Abandoned
-
2001
- 2001-09-04 ES ES01966807T patent/ES2250469T3/en not_active Expired - Lifetime
- 2001-09-04 JP JP2002524594A patent/JP2004507563A/en active Pending
- 2001-09-04 AT AT01966807T patent/ATE309850T1/en not_active IP Right Cessation
- 2001-09-04 DE DE60115076T patent/DE60115076D1/en not_active Expired - Lifetime
- 2001-09-04 EP EP01966807A patent/EP1324809B1/en not_active Expired - Lifetime
- 2001-09-04 WO PCT/AU2001/001113 patent/WO2002020112A1/en not_active Ceased
- 2001-09-04 CA CA002420881A patent/CA2420881C/en not_active Expired - Fee Related
- 2001-09-04 NZ NZ524400A patent/NZ524400A/en not_active IP Right Cessation
-
2003
- 2003-03-04 US US10/377,729 patent/US7238379B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20040081734A1 (en) | 2004-04-29 |
| ES2250469T3 (en) | 2006-04-16 |
| CA2420881C (en) | 2008-05-20 |
| AUPQ987400A0 (en) | 2000-09-28 |
| DE60115076D1 (en) | 2005-12-22 |
| CA2420881A1 (en) | 2002-03-14 |
| WO2002020112A1 (en) | 2002-03-14 |
| US7238379B2 (en) | 2007-07-03 |
| EP1324809A4 (en) | 2004-08-18 |
| EP1324809B1 (en) | 2005-11-16 |
| JP2004507563A (en) | 2004-03-11 |
| EP1324809A1 (en) | 2003-07-09 |
| ATE309850T1 (en) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1324809B1 (en) | Process for selectively extracting bioactive components | |
| US8735573B2 (en) | Method to recover bioactive compounds | |
| US6528099B1 (en) | Method for selectively obtaining antioxidant rich extracts from citrus fruits | |
| USRE41537E1 (en) | Citrus peel juice | |
| AU2002329468B2 (en) | Process for the preparation of anthocyanin-containing products | |
| US9351518B2 (en) | Phenolics extraction and use | |
| CN108553527B (en) | Preparation method of total flavone extract of prinsepia utilis royle | |
| US20100159115A1 (en) | Flavonoid-rich citrus extract process | |
| AU2001287353B2 (en) | Process for selectively extracting bioactive components | |
| JP2004210682A (en) | Method for producing composition highly containing functional component of citrus | |
| AU2001287353A1 (en) | Process for selectively extracting bioactive components | |
| US20060116509A1 (en) | Manufacture of limonoid compounds | |
| JP4856298B2 (en) | Production method of polyphenol | |
| Schoch et al. | Recovery of limonoid glucosides from citrus molasses | |
| WO2005070443A1 (en) | Timber bark extract | |
| KR102518775B1 (en) | Method for separating and purifying nobiletin from citrus preicarp | |
| JPH10121044A (en) | Antioxidant, active hydrogen eliminator and their application | |
| Karakaya | Purification of polyphenolic compounds from crude olive leaf extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 04 SEP 2021 BY PHILLIPS ORMONDE FITZPATRICK Effective date: 20140815 |
|
| EXPY | Patent expired |